e-4c News Portal - Facing price controls, pharma industry cranks up heat on Congress

For decades, the drug industry has yelled bloody murder each time Congress considered a regulatory measure that threatened its profits. But the hyperbole reached a new pitch in recent weeks as the Senate moved to adopt modest drug pricing negotiation measures in the Inflation Reduction Act.

Click Here to read the entire article...